Status:
COMPLETED
Physical Disability in Patients Treated With Betaferon
Lead Sponsor:
Bayer
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
To gather Observation data about physical disability progression, safety and adherence during the use of Betaferon in daily practice. Patients with any type of Multiple Sclerosis (MS) (MRRS) (PSMS), u...
Eligibility Criteria
Inclusion
- Patients with a first demyelinating event suggestive of MS, as well as patients with remittent recurrent MS (RRMS), secondary progressive MS (SPMS) and primary progressive MS (PPMS) will be able to join the study.
Exclusion
- Pregnancy
- Patients with a history of hypersensitivity to natural or recombinant interferon-beta, human albumin or to any of the excipients
- Patients with a history of severe depressive disorders and/or suicidal ideation
- Patient with decompensated liver disease
- Patient with epilepsy not adequately controlled by treatment
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT00873340
Start Date
October 1 2007
End Date
January 1 2011
Last Update
June 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Colombia